A genomic-augmented multivariate prognostic model for the survival of natural-killer/T-cell lymphoma patients from an international cohort.
Saved in:
| Title: | A genomic-augmented multivariate prognostic model for the survival of natural-killer/T-cell lymphoma patients from an international cohort. |
|---|---|
| Authors: | Lim JQ; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.; Lymphoma Genomic Translational Research Laboratory, Cellular and Molecular Research, National Cancer Centre Singapore, Singapore.; ONCO-ACP, Duke-NUS Medical School, Singapore., Huang D; Lymphoma Genomic Translational Research Laboratory, Cellular and Molecular Research, National Cancer Centre Singapore, Singapore.; ONCO-ACP, Duke-NUS Medical School, Singapore., Chan JY; Division of Medical Oncology, National Cancer Centre Singapore, Singapore., Laurensia Y; Lymphoma Genomic Translational Research Laboratory, Cellular and Molecular Research, National Cancer Centre Singapore, Singapore., Wong EKY; Lymphoma Genomic Translational Research Laboratory, Cellular and Molecular Research, National Cancer Centre Singapore, Singapore., Cheah DMZ; Lymphoma Genomic Translational Research Laboratory, Cellular and Molecular Research, National Cancer Centre Singapore, Singapore., Chia BKH; Lymphoma Genomic Translational Research Laboratory, Cellular and Molecular Research, National Cancer Centre Singapore, Singapore., Chuang WY; Department of Anatomic Pathology, Chang Gung Memorial Hospital at Linkou, Taoyuan, Taiwan.; Chang Gung University, Taoyuan, Taiwan., Kuo MC; Chang Gung University, Taoyuan, Taiwan.; Division of Hematology-Oncology, Chang Gung Memorial Hospital at Linkou, Taoyuan, Taiwan., Su YJ; Division of Hematology-Oncology, Chang Gung Memorial Hospital at Linkou, Taoyuan, Taiwan., Cai QQ; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China., Feng Y; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China., Rao H; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China., Feng LN; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China., Wei PP; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China., Chen JR; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China., Han BW; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China., Lin GW; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China., Cai J; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China., Fang Y; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China., Tan J; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.; Lymphoma Genomic Translational Research Laboratory, Cellular and Molecular Research, National Cancer Centre Singapore, Singapore.; Laboratory of Cancer Epigenome, Division of Medical Sciences, National Cancer Centre Singapore, Singapore., Hong H; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China., Liu Y; Guangdong Provincial People's Hospital, Guangdong, China.; Guangdong Academy of Medical Sciences, Guangdong, China., Zhang F; Guangdong Provincial People's Hospital, Guangdong, China.; Guangdong Academy of Medical Sciences, Guangdong, China., Li W; Guangdong Provincial People's Hospital, Guangdong, China.; Guangdong Academy of Medical Sciences, Guangdong, China., Poon MLM; Department of Haematology-Oncology, National University Cancer Institute of Singapore, National University Health System, Singapore., Ng SB; Department of Pathology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore City, Singapore.; Cancer Science Institute of Singapore, National University of Singapore, Singapore City, Singapore., Jeyasekharan A; Cancer Science Institute of Singapore, National University of Singapore, Singapore City, Singapore.; Department of Haematology-Oncology, National University Health System, Singapore City, Singapore., Ha JCH; Lymphoma Genomic Translational Research Laboratory, Division of Medical Oncology, National Cancer Centre Singapore, Singapore City, Singapore., Khoo LP; Lymphoma Genomic Translational Research Laboratory, Division of Medical Oncology, National Cancer Centre Singapore, Singapore City, Singapore., Chin ST; Lymphoma Genomic Translational Research Laboratory, Division of Medical Oncology, National Cancer Centre Singapore, Singapore City, Singapore., Pang WL; Lymphoma Genomic Translational Research Laboratory, Cellular and Molecular Research, National Cancer Centre Singapore, Singapore., Kee R; Lymphoma Genomic Translational Research Laboratory, Division of Medical Oncology, National Cancer Centre Singapore, Singapore City, Singapore., Cheng CL; Department of Pathology, Singapore General Hospital, Singapore City, Singapore., Grigoropoulos NF; Department of Haematology, Singapore General Hospital, Singapore City, Singapore., Tang T; ONCO-ACP, Duke-NUS Medical School, Singapore., Tao M; Division of Medical Oncology, National Cancer Centre Singapore, Singapore., Farid M; Division of Medical Oncology, National Cancer Centre Singapore, Singapore., Puan KJ; Singapore Immunology Network (SIgN), A*STAR (Agency for Science, Technology and Research), Singapore City, Singapore., Xiong J; Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics,National Research Center for Translational Medicine at Shanghai Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China., Zhao WL; Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics,National Research Center for Translational Medicine at Shanghai Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China., Khor CC; Genome Institute of Singapore, Singapore City, Singapore., Hwang W; Director's office, National Cancer Centre, Singapore City, Singapore., Kim WS; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea., Campo E; Institut D'Investigacions Biomediques August Pi I Sunyer, Hospital Clinic, University of Barcelona, Barcelona, Spain., Tan P; Cancer Science Institute of Singapore, National University of Singapore, Singapore City, Singapore.; Genome Institute of Singapore, Singapore City, Singapore.; Programme in Cancer and Stem Cell Biology, Duke-NUS Medical School, Singapore City, Singapore., Teh BT; Laboratory of Cancer Epigenome, Division of Medical Sciences, National Cancer Centre Singapore, Singapore.; Cancer Science Institute of Singapore, National University of Singapore, Singapore City, Singapore.; Programme in Cancer and Stem Cell Biology, Duke-NUS Medical School, Singapore City, Singapore., Chng WJ; Department of Haematology-Oncology, National University Cancer Institute of Singapore, National University Health System, Singapore.; Cancer Science Institute of Singapore, National University of Singapore, Singapore City, Singapore., Rötzschke O; Singapore Immunology Network (SIgN), A*STAR (Agency for Science, Technology and Research), Singapore City, Singapore., Tousseyn T; Translational Cell and Tissue Research Lab, Department of Imaging and Pathology, KU Leuven, Leuven, Belgium.; Department of Pathology, UZ Leuven, Leuven, Belgium., Huang HQ; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China., Rozen S; Programme in Cancer and Stem Cell Biology, Duke-NUS Medical School, Singapore City, Singapore.; Centre for Computational Biology, Duke-NUS Medical School, Singapore City, Singapore., Lim ST; Director's office, National Cancer Centre, Singapore City, Singapore.; Office of Education, Duke-NUS Medical School, Singapore City, Singapore., Shih LY; Chang Gung University, Taoyuan, Taiwan.; Division of Hematology-Oncology, Chang Gung Memorial Hospital at Linkou, Taoyuan, Taiwan., Bei JX; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China., Ong CK; Lymphoma Genomic Translational Research Laboratory, Cellular and Molecular Research, National Cancer Centre Singapore, Singapore.; Genome Institute of Singapore, Singapore City, Singapore.; Cancer and Stem Cell Biology, Duke-NUS Graduate Medical School, Singapore City, Singapore. |
| Source: | American journal of hematology [Am J Hematol] 2022 Sep; Vol. 97 (9), pp. 1159-1169. Date of Electronic Publication: 2022 Jul 05. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
